Goh N, Simonca C, Verroiotou M, Jenkins S
Womens Health Rep (New Rochelle). 2023; 4(1):409-414.
PMID: 37638330
PMC: 10457637.
DOI: 10.1089/whr.2023.0021.
Genc E, Sarac I, Arslan H, Eskazan A
Oncol Ther. 2023; 11(2):145-152.
PMID: 37178373
PMC: 10182356.
DOI: 10.1007/s40487-023-00229-4.
Ceronie B, Hart T, Belete D, Ramani L, Bahra A
Clin Med (Lond). 2021; 21(6):e648-e655.
PMID: 34862227
PMC: 8806310.
DOI: 10.7861/clinmed.CM-2021-0223.
Ramzi S, Cant P
BJS Open. 2021; 5(2).
PMID: 33688948
PMC: 7944494.
DOI: 10.1093/bjsopen/zraa023.
Hultstrand C, Coe A, Lilja M, Hajdarevic S
Scand J Prim Health Care. 2020; 38(2):238-247.
PMID: 32314634
PMC: 8570742.
DOI: 10.1080/02813432.2020.1753388.
Does the perception of severity of medical error differ between varying levels of clinical seniority?.
Khan I, Arsanious M
Adv Med Educ Pract. 2018; 9:443-452.
PMID: 29942171
PMC: 6007198.
DOI: 10.2147/AMEP.S146474.
Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care.
Jensen H, Torring M, Vedsted P
BMC Cancer. 2017; 17(1):627.
PMID: 28874125
PMC: 5585953.
DOI: 10.1186/s12885-017-3623-8.
Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process.
Buvarp Dyrop H, Vedsted P, Raedkjaer M, Safwat A, Keller J
Sarcoma. 2017; 2016:8639272.
PMID: 28115911
PMC: 5220485.
DOI: 10.1155/2016/8639272.
Delay in Cancer Diagnosis: Causes and Possible Solutions.
H Al-Azri M
Oman Med J. 2016; 31(5):325-6.
PMID: 27602184
PMC: 4996960.
DOI: 10.5001/omj.2016.65.
The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability.
Ingeman M, Christensen M, Bro F, Knudsen S, Vedsted P
BMC Cancer. 2015; 15:421.
PMID: 25990247
PMC: 4445271.
DOI: 10.1186/s12885-015-1424-5.
Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients.
Jensen H, Torring M, Olesen F, Overgaard J, Fenger-Gron M, Vedsted P
BMC Cancer. 2015; 15:308.
PMID: 25900050
PMC: 4412104.
DOI: 10.1186/s12885-015-1317-7.
Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study.
Jensen H, Torring M, Olesen F, Overgaard J, Vedsted P
BMC Cancer. 2014; 14:636.
PMID: 25175155
PMC: 4164756.
DOI: 10.1186/1471-2407-14-636.
Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database.
Neal R, Din N, Hamilton W, Ukoumunne O, Carter B, Stapley S
Br J Cancer. 2013; 110(3):584-92.
PMID: 24366304
PMC: 3915139.
DOI: 10.1038/bjc.2013.791.
The Two-Week Referral System for colorectal cancer--not fit for purpose.
Padwick R, Bajwa A, Shaw A, Leung E, Francombe J, Stellakis M
Int J Colorectal Dis. 2013; 28(11):1531-4.
PMID: 23748570
DOI: 10.1007/s00384-013-1730-9.
Variation in use of the 2-week referral pathway for suspected cancer: a cross-sectional analysis.
Meechan D, Gildea C, Hollingworth L, Richards M, Riley D, Rubin G
Br J Gen Pract. 2012; 62(602):e590-7.
PMID: 22947579
PMC: 3426597.
DOI: 10.3399/bjgp12X654551.
Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm.
Hippisley-Cox J, Coupland C
Br J Gen Pract. 2012; 62(594):e29-37.
PMID: 22520670
PMC: 3252537.
DOI: 10.3399/bjgp12X616346.
Referral patterns, clinical examination and the two-week-rule for breast cancer: a cohort study.
McCain S, Newell J, Badger S, Kennedy R, Kirk S
Ulster Med J. 2012; 80(2):68-71.
PMID: 22347745
PMC: 3229848.
Cancer patients' concerns regarding access to cancer care: perceived impact of waiting times along the diagnosis and treatment journey.
Paul C, Carey M, Anderson A, Mackenzie L, Sanson-Fisher R, Courtney R
Eur J Cancer Care (Engl). 2011; 21(3):321-9.
PMID: 22111696
PMC: 3410528.
DOI: 10.1111/j.1365-2354.2011.01311.x.
Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study.
Prades J, Espinas J, Font R, Argimon J, Borras J
Br J Cancer. 2011; 105(6):753-9.
PMID: 21829194
PMC: 3171014.
DOI: 10.1038/bjc.2011.308.
Identifying suspected breast cancer: development and validation of a clinical prediction rule.
McCowan C, Donnan P, Dewar J, Thompson A, Fahey T
Br J Gen Pract. 2011; 61(586):e205-14.
PMID: 21619744
PMC: 3080225.
DOI: 10.3399/bjgp11X572391.
